QVT Financial LP 4
4 · Roivant Sciences Ltd. · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
Roivant (ROIV) QVT Financial (Director) Sells 1.44M Shares
What Happened
QVT Financial LP (reported as "Director by Deputization") sold a total of 1,438,163 common shares of Roivant Sciences Ltd. (ROIV) in multiple open-market transactions between June 26 and June 30, 2026, for aggregate proceeds of approximately $49.35 million. Individual trades: 300,783 shares @ $33.92 (≈ $10,202,559) and 325,000 @ $34.07 (≈ $11,072,750) on 2026-06-26; 200,000 @ $34.44 (≈ $6,888,000) and 600,000 @ $34.59 (≈ $20,754,000) on 2026-06-29; and 12,380 @ $35.28 (≈ $436,766) on 2026-06-30. These were sales (not purchases or exercises).
Key Details
- Dates & prices: 2026-06-26 (300,783 @ $33.92; 325,000 @ $34.07), 2026-06-29 (200,000 @ $34.44; 600,000 @ $34.59), 2026-06-30 (12,380 @ $35.28).
- Total sold: 1,438,163 shares for ~$49,354,075.
- Shares owned after transactions: QVT (via affiliated entities) may be deemed to beneficially own 23,723,074 common shares (per filing footnote).
- Footnotes: F1 clarifies the post-transaction aggregate beneficial ownership figure applies to QVT and its GP; F2 states QVT provides advisory services to affiliated entities and disclaims beneficial ownership except to the extent of any pecuniary interest.
- Filing: Form 4 filed 2026-06-30 reporting transactions from 2026-06-26 onward; no late-filing indication in the report.
Context
This filing reflects institutional selling by an investment manager/affiliate group rather than a straightforward executive buy or sell by an individual CEO/CFO. The filing’s footnotes indicate ownership is held through affiliated entities and that QVT disclaims full beneficial ownership except for pecuniary interest—useful to know when assessing how these sales affect insider alignment with shareholders. The report is factual and does not state motives; sales by investment firms can be for portfolio management or liquidity rather than a signal about the company’s outlook.
Insider Transaction Report
- Sale
Common Shares
[F1][F2]2026-06-26$33.92/sh−300,783$10,202,559→ 14,826,546 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-06-26$34.07/sh−325,000$11,072,750→ 14,501,546 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-06-29$34.44/sh−200,000$6,888,000→ 14,301,546 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-06-29$34.59/sh−600,000$20,754,000→ 13,701,546 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
[F1][F2]2026-06-30$35.28/sh−12,380$436,766→ 13,689,166 total(indirect: Held by QVT Financial Investment Cayman Ltd.)
Footnotes (2)
- [F1]Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.
- [F2]QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.